右美托咪定对脓毒性休克患者乳酸清除率的影响:一项多中心随机对照试验的亚组分析
本研究为多中心随机对照试验的事后亚组分析,纳入机械通气的成人脓毒性休克患者,随机接受含或不含右美托咪定的镇静策略(右美托咪定组60例,非右美托咪定组51例)。主要终点为6小时乳酸清除率(随机至6小时乳酸下降百分比)。右美托咪定组6小时乳酸清除率数值上高于非右美托咪定组(23.3 ± 29.8 vs. 11.1 ± 54.4),但未达统计学显著(均差12.2,95%CI -4.4至28.8);校正随机时乳酸水平后,右美托咪定组6小时乳酸清除率显著更高(校正均差18.5,95%CI 2.2-34.9)。两组28天死亡率无显著差异(13例[22%] vs. 18例[35%],P=0.11)。
要点
- 在机械通气的脓毒性休克成人患者中,右美托咪定镇静组6小时乳酸清除率数值上高于非右美托咪定组(23.3 ± 29.8 vs. 11.1 ± 54.4),但未达统计学显著(均差12.2,95%CI -4.4至28.8)。
- 校正随机时乳酸水平后,右美托咪定组6小时乳酸清除率显著更高(校正均差18.5,95%CI 2.2-34.9)。
- 右美托咪定组随机时中位血清乳酸值低于非右美托咪定组(4.0 mmol/L vs. 4.8 mmol/L,P=0.053)。
- 两组28天死亡率无显著差异(右美托咪定组13例[22%] vs. 非右美托咪定组18例[35%],P=0.11)。
- 研究人群病情较重,中位APACHE II评分为25分(四分位距19-31)。
适用人群与场景
- 机械通气的成人脓毒性休克患者(随机分组时接受通气)。
研究设计与关键结果
- 研究类型:多中心随机对照试验的事后亚组分析。
- 样本量与分组:右美托咪定组60例,非右美托咪定组51例。
- 人群:机械通气的成人脓毒性休克患者,中位APACHE II评分25分(四分位距19-31)。
- 干预与对照:镇静策略含右美托咪定 vs. 不含右美托咪定。
- 主要终点:6小时乳酸清除率(随机至6小时乳酸下降百分比)。右美托咪定组23.3 ± 29.8 vs. 非右美托咪定组11.1 ± 54.4,均差12.2(95%CI -4.4至28.8),未达统计学显著;校正随机时乳酸水平后,校正均差18.5(95%CI 2.2-34.9),右美托咪定组显著更高。
- 随机时中位血清乳酸值:右美托咪定组4.0 mmol/L vs. 非右美托咪定组4.8 mmol/L(P=0.053)。
- 28天死亡率:右美托咪定组13例(22%) vs. 非右美托咪定组18例(35%),P=0.11,无统计学显著差异。
证据类型、等级与局限
- 证据类型:多中心随机对照试验的事后亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在机械通气的脓毒性休克患者中,含右美托咪定的镇静策略可能提高6小时乳酸清除率,但28天死亡率无显著差异;作者认为右美托咪定镇静较无右美托咪定镇静可增加乳酸清除率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Lactate clearance is useful to guide initial resuscitation of patients with septic shock. We conducted this study to evaluate whether dexmedetomidine increases lactate clearance in patients with septic shock. This was a randomized controlled trial that involved a post hoc subgroup analysis. Adult patients with septic shock under ventilation were randomized to receive sedation strategy with or without dexmedetomidine (60 in the dexmedetomidine and 51 in the nondexmedetomidine groups). The primary outcome was the lactate clearance at 6 h, defined as the percent decrease in lactate from randomization to 6 h after. The median Acute Physiology and Chronic Health Evaluation II score was 25 (interquartile range 19-31). The median serum lactate value at randomization was lower in the dexmedetomidine group than in the nondexmedetomidine group (4.0 mmol/L vs. 4.8 mmol/L; P = 0.053). The lactate clearance at 6 h was higher in the dexmedetomidine group, although this was not statistically significant (23.3 ± 29.8 vs. 11.1 ± 54.4, mean difference 12.2, 95% confidence interval (CI), -4.4 to 28.8). After adjusting for the lactate level at randomization, lactate clearance at 6 h was significantly higher in the dexmedetomidine group (adjusted mean difference 18.5, 95% CI, 2.2-34.9). There was no statistically significant difference in the 28-day mortality between the dexmedetomidine and the nondexmedetomidine groups (13 [22%] vs. 18 [35%] patients, P = 0.11). In conclusion, among mechanically ventilated patients with septic shock, sedation with dexmedetomidine resulted in increased lactate clearance compared with sedation without dexmedetomidine.
参考来源
- Miyamoto K, Nakashima T, Shima N, et al. Effect of Dexmedetomidine on Lactate Clearance in Patients With Septic Shock: A Subanalysis of a Multicenter Randomized Controlled Trial. Shock. 2018. PMID: 29117063. doi:10.1097/SHK.0000000000001055
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。